These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5218380)

  • 21. Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
    Projan SJ; Nesin M; Dunman PM
    Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus.
    John CC; Schreiber JR
    Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased resistance to staphylococcal infetion following administration of beef heart extract.
    McCo JC; Verwe WF; Bass JA
    Tex Rep Biol Med; 1969; 27(2):457-65. PubMed ID: 5350365
    [No Abstract]   [Full Text] [Related]  

  • 24. [Management of staphylococcal diseases].
    Ruiloba Benítez J
    Gac Med Mex; 1965 Dec; 95(12):1115-47. PubMed ID: 5889432
    [No Abstract]   [Full Text] [Related]  

  • 25. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.
    Therrien R; Lacasse P; Grondin G; Talbot BG
    Vaccine; 2007 Jun; 25(27):5053-61. PubMed ID: 17532546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
    Fattom AI; Horwith G; Fuller S; Propst M; Naso R
    Vaccine; 2004 Feb; 22(7):880-7. PubMed ID: 15040941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine could help fight deadly hospital-acquired infections.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Mar; 13(6):9-10, 12. PubMed ID: 12449105
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of intramammary vaccination on experimental staphylococcal infection (author's transl)].
    Groothuis DG; Grootenhuis G
    Tijdschr Diergeneeskd; 1981 Mar; 106(6):304-13. PubMed ID: 7195083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcal immunity: production of staphylococcal hemagglutinins in rabbits receiving staphylococcal vaccine.
    WELD JT; ROGERS DE
    Proc Soc Exp Biol Med; 1960 Feb; 103():311-4. PubMed ID: 13843829
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contribution to the study of the factors of pathogenicity of staphylococci in relation to specific immunity. II. Morpho-lesional aspects obtained in specifically immunized rabbits infected with homologous and heterologous strains of pathogenic staphylococci intradermally injected].
    Nestoresco N; Popovici M; Alexenco E; Trifu P
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):899-910. PubMed ID: 5836095
    [No Abstract]   [Full Text] [Related]  

  • 31. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide.
    Maira-Litran T; Kropec A; Goldmann D; Pier GB
    Vaccine; 2004 Feb; 22(7):872-9. PubMed ID: 15040940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent staphylococcal infection in families.
    Steele RW
    Arch Dermatol; 1980 Feb; 116(2):189-90. PubMed ID: 7356349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the subcutaneous abscess formation and immunity in staphylococcal infection of mice.
    Tadokoro I
    Jpn J Exp Med; 1966 Feb; 36(1):6passim. PubMed ID: 5297258
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
    Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
    J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective effects of active immunization against alpha hemolysin of Staphylococcus aureus].
    Wleklinski CG; Neubüser U; Ronneberger H; Hungerer KD; Schaeg W; Blobel H
    Zentralbl Veterinarmed B; 1982 Sep; 29(8):596-603. PubMed ID: 7180248
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vaccination against influenza superfluous in patients with (recurrent) staphylococcal infections].
    Sigurdsson V; Lammers JW; Verhoef EA; van Vloten WA
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2316-7. PubMed ID: 7501066
    [No Abstract]   [Full Text] [Related]  

  • 37. Staphylococcal bacterin for treatment of chronic staphylococcal blepharitis in the dog.
    Chambers ED; Severin GA
    J Am Vet Med Assoc; 1984 Aug; 185(4):422-5. PubMed ID: 6469840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR; Black S
    Expert Rev Vaccines; 2005 Oct; 4(5):669-76. PubMed ID: 16221068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcal lysate fails to elicit nonspecific immune enhancement in a simulated surgical infection.
    Brown GL; Cobb JP; Brown CM; Polk HC
    Am Surg; 1984 Dec; 50(12):663-5. PubMed ID: 6391313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Staphylococcus aureus immunotherapy: current status and prospects.
    García-Lara J; Foster SJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):552-7. PubMed ID: 19733119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.